key: cord-0734913-kvaysf04 authors: Jenkins, Victoria A.; Silbernagl, Guenter; Baer, Lorraine R.; Hoet, Bernard title: The Epidemiology of Infectious Diseases in Europe in 2020 versus 2017-2019 and the Rise of Tick-borne Encephalitis (1995-2020) date: 2022-05-23 journal: Ticks Tick Borne Dis DOI: 10.1016/j.ttbdis.2022.101972 sha: 6688a4cfc260864b59541ba60074c32dc42b6ced doc_id: 734913 cord_uid: kvaysf04 Health control measures instituted in 2020 to mitigate the COVID-19 pandemic decreased the case numbers of many infectious diseases across Europe. One notable exception was tick-borne encephalitis (TBE). In Austria, Germany, Switzerland, Lithuania, and Czech Republic the upturn was significantly higher compared to the average of the three years previously (P<0.0001), with increases of 88%, 48%, 51%, 28% and 18% respectively. Six countries reported TBE incidences of ≥5 cases/100,000, defined as highly endemic by the World Health Organization (WHO). In highly endemic regions the WHO recommend that vaccination be offered to all age groups, including children. Possible factors contributing to this surge may include increased participation in outdoor activities in endemic regions and increased tick counts/tick activity. The emergence in December 2019 of the new coronavirus SARS-CoV-2, the causative agent of COVID-19, quickly swept around the globe, and on 11 th March 2020 the World Health Organization (WHO) declared the COVID-19 pandemic (WHO, 2020) . Consequently, parts of Europe put in place public health policies to contain the spread of the virus. Recent reports from Switzerland (Steffen et al., 2020) and Germany (Ulrich et al., 2021) documented substantial reductions in almost all recorded infectious diseases in 2020 as compared to earlier years. In these countries, one of the only infectious diseases to see an increase during this period was tick-borne encephalitis (TBE) (Steffen et al., 2020; Ulrich et al., 2021) . In this report, we used data from the health departments of various European countries to investigate the prevalence of select infectious diseases under surveillance during 2020, and further explored the trend in TBE cases from 1995 through 2020. Data were sourced from the websites of health departments of the countries listed in The number of cases of TBE were found to have increased in 2020 compared to the average of the three years previously in eleven select European countries: Austria, Germany, Switzerland, Finland, Norway, Lithuania, and the Czech Republic (Table 2 ) as well as in Slovakia, Slovenia, Belgium, and the Netherlands (Table 3 ). In five countries, the increases were significantly (P<0.05) higher -Austria (88%), Germany (48%), Switzerland (51%), Lithuania (28%) and Czech Republic (18%). Significant (P<0.05) decreases in TBE were found in Poland (-40%) and Sweden (-23%). The year 2020 saw the highest ever number of TBE cases since 1995 for eight countries (Austria, Switzerland, Germany, Slovakia, Finland, Norway, Belgium, and the Netherlands) ( Table 3) . The highest notification rates of TBE in 2020 occurred in Lithuania, Latvia, Slovenia, and the Czech Republic, with incidences of 23.94, 11.01, 8.92, and 7.99 cases/100,000 population, respectively (Table 3 and Fig. 1 ). These four countries as well as Estonia (incidence of 5.12) and Switzerland (incidence of 5.31) reported incidences of ≥5 per 100,000/year. Incidences of TBE per country per 100,000 inhabitants in 2020 is shown in Fig. 1 . With few exceptions, the number of cases of a range of infectious diseases, including airborne diseases such as Haemophilus influenzae, Meningococcal disease, and Streptococcus pneumoniae, were significantly decreased in 2020 compared to the average of the three years previously ( Table 2 ). The largest and most consistent decrease was seen in rotavirus, where seven (Germany, Finland, Estonia, Latvia, Lithuania, Hungary, and Poland) of eight countries reporting on rotavirus recorded reductions of 53-93%. Other than TBE, pertussis, influenza, gonorrhea, and chlamydia were the only other infectious diseases to have seen significant (P<0.05) increases in 2020 vs. the mean of the three previous years, and only in select countries. Influenza increased by 4% in Germany, gonorrhea increased by 11% in Switzerland, chlamydia by 7% in Finland and pertussis increased by 162% in Lithuania. Over a 25-year period from 1995-2020, the incidence of TBE across many European countries has trended upwards. Specifically comparing 2020 to the mean incidence of 2017-2019, countries in the alpine regions demonstrated significant increases of 48-88% in TBE, with record number of cases reported in Switzerland and Germany. Other countries that saw a significant increase in TBE cases during this period were Czech Republic (18%) and Lithuania (28%). In contrast, the changes in total TBE cases in other Northern and Eastern European countries were non-significant when compared to data from 2017-2019, with the exception of Sweden and Poland seeing a significant decrease in cases reported. Other notifiable diseases, including airborne diseases such as Haemophilus influenzae, Meningococcal disease, and Streptococcus pneumoniae, were decreased in 2020 in Europe and 7 other countries (Steffen et al., 2020; Sullivan et al., 2020; Ulrich et al., 2021) . The reduction in these infections may be linked to mitigation efforts (including social distancing, school closures, travel restrictions, and mask wearing, and an emphasis on hand washing) put in place to prevent the spread of COVID-19 (Steffen et al., 2020; Sullivan et al., 2020; Ulrich et al., 2021) . Furthermore, day-care closures were likely responsible for the consistently large decline in rotavirus, as interactions between infants and young children were reduced. A potential explanation for the rise in pertussis in Lithuania could be increased health seeking behaviours and subsequent pertussis diagnosis. can also be infected by consuming unpasteurised dairy products (Brockmann et al., 2018; Kohlmaier et al., 2021) . Factors driving TBE incidence can be classified into three areas: (i) tick abundance, (ii) population at risk, and (iii) surveillance characteristics (Martin et al., 2020; Ocias et al., 2019; Ulrich et al., 2021; World Health Organization, 2011) . Tick abundance is related to environmental conditions, including land use, weather, host reservoirs, and climate change, and can be very focal (Süss et al., 2008 ). An earlier occurrence of spring can accelerate tick development (Jaenson et al., 2012) . Additionally, milder winters permit winter activity of ticks and may increase population of hosts to sustain greater tick populations (Süss et al., 2008 Brugger, 2020, 2021) . Interestingly, a 225% increase in visitor frequency to public green spaces, including national parks and public gardens, was reported in the Google Mobility Report of May 2020 for Germany (Schweizer et al., 2021) . Underreporting to surveillance systems in 2020 may have been a factor in some countries where there was a decrease in TBE. One analysis from Poland suggested that access to specialised diagnostic testing for TBE may have been limited during the pandemic due to overburdened healthcare resources (Sulik et al., 2021) . A limitation of this study is that mandatory reporting of infectious diseases varied across countries, and as such, the data found on the websites of health departments were not uniformly available for all countries. In addition, changes in health care seeking behaviour of individuals and the number of laboratory tests conducted during the pandemic may have altered vs the previous years, and these factors may have led to reporting bias for 2020 (Simões, et al., 2020) . The overall trend in number of TBE cases across Europe is on an upward trajectory, although with regional and temporal variations. Several factors may be involved, including global warming and social behaviours. Long-lasting morbidity from TBE, limiting function and quality of life, are seen in up to 30% of those hospitalised with TBE (Bogovič et al., 2018; Kohlmaier et al., 2021) . With no curative treatment available, vaccination remains the most effective method to prevent infection, with reported effectiveness rates of 95-99% (Heinz et al., 2013; Erber et al., 2021) . The WHO recommends TBE vaccination for adults and children in highly endemic (≥5 cases/100,000 population/year) areas and targeted vaccination in specific geographical locations or when participating in at-risk outdoor activities (World Health Organization, 2011). Compliance with TBE vaccination is low in many European countries (Erber and Schmitt, 2018) . Thus, increasing awareness and education regarding vaccination against TBE for those travelling to or residing in endemic areas are critical interventions for addressing this growing public health issue. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Victoria A Jenkins: Conceptualisation, Data extraction, Data analysis, Roles/Writingoriginal draft, Writingreview & editing. Guenter Silbernagl: Data analysis, Writingreview & editing. Lorraine R Baer: Roles/Writingoriginal draft, Writingreview and editing. Bernard Hoet: Conceptualisation, Data analysis, Writingreview & editing. The long-term outcome of tick-borne encephalitis in Central Europe A cluster of two human cases of tick-borne encephalitis (TBE) transmitted by unpasteurised goat milk and cheese in Germany Effectiveness of TBE vaccination in Southern Germany and Latvia Self-reported tick-borne encephalitis (TBE) vaccination coverage in Europe: Results from a cross-sectional study Vaccination and tick-borne encephalitis, central Why is tick-borne encephalitis increasing? A review of the key factors causing the increasing incidence of human TBE in Sweden Clinical characteristics of patients with tickborne encephalitis (TBE): A European multicentre study from Investigating novel approaches to tick-borne encephalitis surveillance in Sweden Transnational exchange of surveillance data reveals previously unrecognized TBEV microfocus Tick-borne encephalitis incidence forecasts for Austria Operational TBE incidence forecasts for Austria Outdoor cycling activity affected by COVID-19 related epidemic-control-decisions Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region Travel restrictions and lockdown during the COVID-19 pandemic-impact on notified infectious diseases in Switzerland Epidemiology of tick-borne encephalitis in -2019) and the impact of the COVID-19 pandemic on the notified incidence of the disease Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia-an overview What makes ticks tick? Climate change, ticks, and tick-borne diseases Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1 -2016 -week Vaccines against tick-borne encephalitis: WHO position paper speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid Table 3. Number of tick-borne encephalitis cases in European countries Gerhard Dobler for discussions regarding epidemiological factors influencing variations in tick density.